Zum Artikel

Dr. Jan Engels Investment Manager

Dr. Jan EngelsInvestment Manager

Dr. Jan Engels

Investment Manager

About me

Team Life Sciences & Chemistry
at HTGF since 2022

CV

Following a bachelor’s degree in biotechnology, Dr. Jan F. Engels completed a PhD in chemistry and nanotechnology in Hong Kong, where he stayed the past 10 years. During his PhD studies he co-founded a medical device start-up in the field of ophthalmology and drug delivery with the position as VP technology. Next to R&D, his focus was on technology patents and business development with successful collaborations with listed companies in US, Europe, and Japan. Next to his start-up position, Jan has a part time lecturer position, teaching Entrepreneurship. After returning to Germany, he joined High-Tech Gründerfonds as an Investment Manager Life Science.

Social Media & contact

My success stories in the HTGF portfolio

12 of 500 Companies
2024

Symphera

Endoscopy

Symphera is a Munich-based startup that is revolutionizing laparoscopic surgery with an innovative system designed to eliminate the need for manual instrument changes. Founded in 2023, Symphera was incubated at …

To the complete profileof Symphera
2024

Sedivention

Gastrointestinal Devices

Sedivention is developing a medical device for a new therapy of obesity. The Blizzard cryocatheter freezes the nerve branches, that transmit an increased, inadequate feeling of hunger to the brain …

To the complete profileof Sedivention
2023

Skinuvita

Aesthetics

Skinuvita is a digital care model for the home use of phototherapy for chronic skin conditions such as psoriasis and neurodermatitis. With the innovative telemedicine system, the prescribed dose is …

To the complete profileof Skinuvita
2023

CustomSurg

Digital Health

CustomSurg, founded in 2021, is a Spin-Off from ETH Zurich and Harvard University. The company is developing software-as-a-medical-device (SaMD) solutions for the optimal selection and placement of orthopaedic implants in …

To the complete profileof CustomSurg
2023

MDTB Cell Manufacturing

Immunology

MDTB stands for drugs, which are based on the immunomodulating drug substance Desacell®. Desacell® is an advanced drug platform based on MSC (Mesenchymal Stromal Cells) and addresses many inflammatory-associated diseases …

To the complete profileof MDTB Cell Manufacturing
2023

RAYDIAX

Imaging & Navigation

The company was founded in 2022 and is headquartered at the STIMULATE research campus in Magdeburg’s “science-harbour”. The scientific company is a spin-off by scientists from the Otto-von-Guericke-University Magdeburg. The …

To the complete profileof RAYDIAX
2023

ReCatalyst

3D Printing, Surface Technologies and New Materials

ReCatalyst is on a mission to revolutionize the proton exchange membrane fuel cell industry by providing customizable next-generation platinum-alloy catalyst solutions. Our primary focus is to enable the massive scalability …

To the complete profileof ReCatalyst
2023

mbiomics

Immunology

Mbiomics is a Munich based microbiome startup company which was founded by Dr. Laura Figulla (CEO), Dr. Johannes Wöhrstein (CTO), and Dr. Markus Rinecker (CMO) in 2020. With its proprietary …

To the complete profileof mbiomics
2022

Refined Laser Systems

Diagnostic

Refined Laser Systems GmbH, based in Münster, Germany, was founded in 2019 as a spin-off from University of Münster by Max Brinkmann, Tim Hellwig and Christoph Seidenstücker. The company’s core …

To the complete profileof Refined Laser Systems
2010

Implandata Ophthalmic Products

Patient Monitoring

IOP GmbH will initiate a paradigm chance in glaucoma therapy by its products for telemetric, 24 hour monitoring of intraocular pressure, allowing personalized patient management.

To the complete profileof Implandata Ophthalmic Products

Guided to exit

12 of 500 Companies
2011

GME

Exit
Aesthetics

GME German Medical Engineering develops and markets a new generation of laser and lightsystems (small, light weight, modular) for the use in cosmetic and medical dermatology.

To the complete profileof GME

Recent posts

Last update 2 days ago
Zum Artikel

News

7. April 2025

Successful exit for HTGF: German Medical Engineering joins the Thomas Group 

Zum Artikel

News

18. November 2024

Sedivention raises €800,000 in pre-seed funding for novel obesity therapy 

Zum Artikel

News

16. September 2024

Symphera Secures €2.4 Million in Seed Financing to revolutionize Laparoscopic Surgery

RAYDIAX_Founders Zum Artikel

News

26. October 2023

RAYDIAX secures €3.5 million in fresh capital to develop its therapy assistance computed tomography system in the fight against cancer

Zum Artikel

News

12. July 2023

ReCatalyst Announces Successful Closing of Oversubscribed Seed Financing Round

Zum Artikel

News

23. March 2023

Microbiome therapeutics biotech mbiomics raises EUR 13 million in first closing of Series A round